Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

10280879001

Roche

5-bromo-2′-désoxyuridine

>97%, crystalline solid, pkg of 1 g

Synonyme(s) :

5-BrdU, 5-bromo-1-(2-désoxy-β-D-ribofuranosyl)uracile, 5-bromo-uracile-désoxyriboside, BUdR

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule empirique (notation de Hill):
C9H11BrN2O5
Numéro CAS:
Poids moléculaire :
307.10
Numéro Beilstein :
30395
Numéro MDL:
Code UNSPSC :
12352204
ID de substance PubChem :

Niveau de qualité

Pureté

>97%

Forme

crystalline solid

Poids mol.

307.1

Conditionnement

pkg of 1 g

Fabricant/nom de marque

Roche

Pf

191-194 °C (dec.) (lit.)

Conditions d'expédition

wet ice

Température de stockage

2-8°C

Chaîne SMILES 

OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O

InChI

1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1

Clé InChI

WOVKYSAHUYNSMH-RRKCRQDMSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

It is conventionally used as a marker for S-phase synthesis of DNA.

Application

5-Bromo-2′-deoxyuridine has been used to label cells in the S-phase of the cell cycle and primary hepatocytes during cell proliferation studies.
Immunochemically detectable nucleotide that can be incorporated into DNA instead of thymidine. Used for in vivo studies of DNA synthesis and for the detection of mutagenic substances, according to the sister chromatid exchange (SCE) method.

Actions biochimiques/physiologiques

Il s'agit d'un analogue de la thymidine utilisé comme agent mutagène en recherche génétique. Il permet une incorporation sélective dans l'ADN cellulaire au cours de la phase S.

Qualité

Purity: 97% (from N), chromatographically homogeneous

Notes préparatoires

Working concentration: According to literature for cell culture, a final concentration of 10 μmol/l has been used.
According to literature, 5 to 50 mg/kg body weight mice have been used for the detection of cell proliferation.

Preparation of Working Solution
Corresponding to the BrdU-labeling reagent which is included in the Roche Cell Proliferation ELISA, BrdU kits and in the Roche 5-Bromo-2′-deoxy-uridine Labeling and Detection Kits, prepare the BrdU working solution by dissolving the substance in PBS to a 10 mM stock solution (MW of BrdU = 307.1 D). For the in vivo use of BrdU dissolve in PBS; for the in vitro use of BrdU, dissolve in double-distilled water at the same 10 mM concentration.
Storage conditions (working solution): -15 to -25 °C

Autres remarques

For life science research only. Not for use in diagnostic procedures.

Pictogrammes

Health hazard

Mention d'avertissement

Danger

Mentions de danger

Classification des risques

Muta. 1B - Repr. 2

Code de la classe de stockage

13 - Non Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Hwan-Ki Kim et al.
Experimental neurobiology, 29(6), 417-424 (2020-12-08)
The myelination of axons in the vertebrate nervous system through oligodendrocytes promotes efficient axonal conduction, which is required for the normal function of neurons. The central nervous system (CNS) can regenerate damaged myelin sheaths through the process of remyelination, but
Yukinobu Goto et al.
American journal of physiology. Cell physiology, 285(2), C253-C259 (2003-04-04)
The present study was designed to develop methods to study the production and release of monocytes from the bone marrow using the thymidine analog 5'-bromo-2'-deoxyuridine (BrdU). Dividing monocytes in bone marrow were labeled with BrdU (MOBrdU), and their release into
Effects of Wnt5a protein on proliferation and apoptosis in JAR choriocarcinoma cells
Peng S, et al.
Molecular Medicine Reports, 4(1), 99-104 (2011)
K M Connolly et al.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 41(1), 1-6 (1993-01-01)
Proliferating cell nuclear antigen (PCNA) was evaluated as a marker of cell proliferation in formalin-fixed rat liver tissue through a comparative study with the thymidine analogue 5-bromo-2'-deoxyuridine (BrdU). The comparison was conducted through the introduction of a dual immunohistochemical procedure
Loss of Integrin $\alpha$v$\beta$8 in Murine Hepatocytes Accelerates Liver Regeneration
Greenhalgh SN, et al.
The American Journal of Pathology, 189(2), 258-271 (2019)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique